Top Digital Health Startups
A useful filter past funding-round vanity.
A live framework for tracking digital health startups — buyer, business model, clinical evidence and unit economics.
"Which digital health startups are durable — and which are funding-round-driven?"
Durable startups have clinical evidence, defined buyer, real unit economics and platform extensibility. Funding alone is not a signal.
Digital health startup tracking should reward buyer clarity, clinical evidence and unit economics — not funding-round size.
What we’re seeing in the data.
Buyer clarity is the strongest filter
Provider / payer / pharma / employer / consumer.
Clinical evidence is currency
Peer-reviewed outcomes data.
Unit economics matter
Burn rate vs payer renewal.
How to think about it.
-
01
Define buyer
Provider / payer / pharma / employer / consumer.
-
02
Score clinical evidence
Published outcomes.
-
03
Test unit economics
CAC / LTV / margin.
-
04
Score platform extensibility
Beyond first product.
What separates a good answer from a defensible one.
EU/Asia under-tracked.
Frequent pivots = thesis weakness.
Repeat operators.
Where the signal comes from.
Common questions.
Best signal?
Buyer clarity + clinical evidence.
Funding alone?
Not a signal.
Want this answered on your data?
We build decision systems on top of analyses like this — so the next question takes minutes, not weeks.
Talk to a strategist